Related Experiment Video
Updated: May 23, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent
Tiejun Zhang1, Yuwen Li, Kyeong Ah Park
1Department of Pharmacology, Research Institute for Medical Science, Infection Signaling Network Research Center, Daejeon Regional Cancer Center, Daejeon, Republic of Korea.
Abstract:
Targeted disruption of STAT3 function has proven to be a useful cancer therapeutic approach by inducing apoptotic cell death. Cucurbitacin is currently under development as a small molecule of STAT3 inhibitor to trigger cell death in many cancers. Here, we systematically studied the molecular mechanisms underlying cucurbitacin-induced cell death, in particular the involvement of autophagy. Treatment with cucurbitacin resulted in non-apoptotic cell death in a caspase-independent manner. Notably, cucurbitacin enhanced excessive conversion of lipidated LC3 (LC3-II) and accumulation of autophagosomes in many cell types. Such autophagy and cell death induced by cucurbitacin were independent of its ability to inhibit STAT3 function, but mainly mediated by enhanced production of mitochondrial-derived reactive oxygen species (ROS), and subsequently activation of extracellular signal-regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK). Interestingly, both the autophagy inhibitor wortmannin and knockdown of Atg5 or Beclin 1 failed to rescue the cells from cucurbitacin-induced cell death, as suppression of autophagy induced the mode of cell death to shift from autophagic cell death to caspase-dependent apoptosis. Thus the present study provides new insights into the molecular mechanisms underlying cucurbitacin-mediated cell death and supports cucurbitacin as a potential anti-cancer drug through modulating the balance between autophagic and apoptotic modes of cell death.
Insights
Cucurbitacin triggers cancer cell death via autophagy and reactive oxygen species, independent of STAT3 inhibition. This suggests cucurbitacin as a potential anti-cancer drug by modulating cell death pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Signal transducer and activator of transcription 3 (STAT3) inhibition is a validated cancer therapy strategy.
- Cucurbitacin is a small molecule STAT3 inhibitor investigated for cancer treatment.
- Understanding cucurbitacin's precise molecular mechanisms, including its role in autophagy, is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the molecular mechanisms of cucurbitacin-induced cell death.
- To investigate the specific involvement of autophagy in cucurbitacin's anti-cancer effects.
- To determine if cucurbitacin's effects are dependent on STAT3 inhibition.
Main Methods:
- Treatment of various cancer cell types with cucurbitacin.
- Assessment of cell death modes (apoptotic vs. non-apoptotic, caspase-dependent vs. independent).
- Analysis of autophagy markers (LC3-II, autophagosomes) and reactive oxygen species (ROS) production.
- Inhibition of autophagy using wortmannin or genetic knockdown (Atg5, Beclin 1).
- Evaluation of signaling pathway activation (ERK, JNK).
Main Results:
- Cucurbitacin induced non-apoptotic, caspase-independent cell death.
- Enhanced autophagy, indicated by increased LC3-II conversion and autophagosome accumulation, was observed.
- Cucurbitacin's effects were independent of STAT3 inhibition but mediated by mitochondrial ROS production, activating ERK and JNK pathways.
- Autophagy inhibition did not prevent cell death; instead, it shifted the cell death mode to caspase-dependent apoptosis.
Conclusions:
- Cucurbitacin induces cancer cell death primarily through ROS-mediated autophagy and subsequent ERK/JNK activation, not STAT3 inhibition.
- Autophagy plays a complex role, with its suppression potentially leading to apoptosis.
- Cucurbitacin shows promise as an anti-cancer agent by manipulating the balance between autophagic and apoptotic cell death pathways.
Related Concept Videos
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
